Atomwise

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.
Type
Private
HQ
San Francisco, US
Employees
10 (est)
Atomwise is headquartered in San Francisco, US

Atomwise Locations

San Francisco, US

Atomwise Metrics

Atomwise Summary

Total Funding

$6.57 M

Latest funding size

$6 M

Time since last funding

over 1 year

Investors

We estimate that Atomwise's latest funding round in June 2015 was $6 M. In total, Atomwise has raised $6.57 M

Atomwise Online Presence

Atomwise Company Life

You may also be interested in